1. From the Department of Biotechnology and Molecular Medicine (T.T.R., J.E.M., M.G., T.H., A.P., I.K., S.Y.-H.), A.I. Virtanen Institute, Kuopio University, Finland; National NMR facility (M.I.K., R.A.K.), A.I. Virtanen Institute, Kuopio University, Finland; Ludwig Institute for Cancer Research (M.G.A., S.A.S.), Royal Melbourne Hospital, Victoria, Australia; and the Molecular/Cancer Biology Laboratory (K.A.), Haartman Institute, University of Helsinki, Finland.